Front. Neurol. Frontiers in Neurology Front. Neurol. 1664-2295 Frontiers Media S.A. 10.3389/fneur.2016.00232 Neuroscience Correction Corrigendum: Unmet Needs in the Management of Cervical Dystonia Contarino Maria Fiorella 1 2 Smit Marenka 3 van den Dool Joost 3 4 5 Volkmann Jens 6 † Tijssen Marina A. J. 3 * † 1Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands 2Department of Neurology, Haga Teaching Hospital, Den Haag, Netherlands 3Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands 4Faculty of Health, ACHIEVE Centre of Applied Research, Amsterdam University of Applied Sciences, Amsterdam, Netherlands 5Department of Neurology, Academic Medical Center, Amsterdam, Netherlands 6Department of Neurology, University Clinic of Würzburg, Würzburg, Germany

Edited and Reviewed by: Alberto Albanese, Catholic University of the Sacred Heart, Italy

 *Correspondence: Marina A. J. Tijssen, m.a.j.de.koning-tijssen@umcg.nl

†Jens Volkmann and Marina A. J. Tijssen contributed equally to the manuscript.

Specialty section: This article was submitted to Movement Disorders, a section of the journal Frontiers in Neurology

 19 12 2016 2016 7 232 15 11 2016 02 12 2016 Copyright © 2016 Contarino, Smit, van den Dool, Volkmann and Tijssen. 2016 Contarino, Smit, van den Dool, Volkmann and Tijssen

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Unmet Needs in the Management of Cervical Dystonia by Contarino MF, Smit M, van den Dool J, Volkmann J, Tijssen MA. Front Neurol (2016) 7:165. doi: 10.3389/fneur.2016.00165 cervical dystonia botulinum toxin deep brain stimulation physical therapy modalities non-motor features Description of the Mistake Being Fixed

In the original article, we neglected to thank our sponsor, European Cooperation in Science and Technology (COST), Action BM1101 “European network for the study of dystonia syndromes.” The authors apologize for this oversight.

This error does not change the scientific conclusions of the article in any way.

The correct text of the acknowledgments should read as below.

 Acknowledgments and Funding

This work was supported by European Cooperation in Science and Technology (COST) Action BM1101 “European network for the study of dystonia syndromes”.

 Conflict of Interest Statement

MC, Advisory board: Medtronic, Boston Scientific, is co-inventor on a patent application relevant to Deep Brain Stimulation (2014). Speaking fees: Abbvie, Medtronic, Boston Scientific, ECMT. Grant: Stichting Parkinson Fonds. MS: Grants: University Medical Centre Groningen, Stichting Wetenschapsfonds Dystonie Vereniging. JD: Grants: Dutch organizations in scientific research, the Fonds Nutsohra, Jacques and Gloria Gossweiler foundation and Stichting Wetenschapsfonds Dystonie Vereniging. JV: advisory boards: Boston Scientific, Medtronic; grant support: Boston Scientific, Medtronic; Speaking fees: Boston Scientific, Medtronic, St. Jude, UCB, TEVA, and Allergan. MT: Grants: Netherlands organization for scientific research-NWO, Medium, Fonds NutsOhra, Prinses Beatrix Fonds, Gossweiler foundation, Stichting wetenschapsfonds dystonie vereniging, Phelps Stichting, educational grants and national DystonieNet grants from Ipsen and Allergan Famaceutics, Merz, Medtronic and Actelion.